GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Type II diabetes mellitus

pathways : Type II diabetes mellitus pathways:

Fullview (zoomIn)


Related Genes to "Type II diabetes mellitus" content :

preload


Related products :

Catalog number Product name Quantity
orb60627 Glipizide Glipizide(Glucotrol) is used to treat high blood sugar levels caused by a type of diabetes mellitus called type 2 diabetes. For research use only. 500 mg
NIDDM3 NIDDM1 Gene non-insulin-dependent diabetes mellitus (common, type 2) 1
NIDDM4 NIDDM2 Gene non-insulin-dependent diabetes mellitus (common, type 2) 2
orb60286 Acarbose Acarbose is an anti-diabetic drug used to treat type 2 diabetes mellitus and, in some countries, prediabetes. For research use only. 1 g
IDE IDDM9 Gene insulin-dependent diabetes mellitus 9
IDDM8 IDDM6 Gene insulin-dependent diabetes mellitus 6
IDDM18 IDDM16 Gene insulin-dependent diabetes mellitus 16
IDDM2 IDDM17 Gene insulin-dependent diabetes mellitus 17
IDDM23 IDDM18 Gene insulin-dependent diabetes mellitus 18
IDDM24 IDDM2 Gene insulin-dependent diabetes mellitus 2
IDDM6 IDDM3 Gene insulin-dependent diabetes mellitus 3
IDDMX IDDM8 Gene insulin-dependent diabetes mellitus 8
IDDM9 IDDM7 Gene insulin-dependent diabetes mellitus 7
IDDM7 IDDM4 Gene insulin-dependent diabetes mellitus 4
IDDM17 IDDM15 Gene insulin-dependent diabetes mellitus 15
IDDM16 IDDM14 Gene insulin-dependent diabetes mellitus 14
IDDM15 IDDM13 Gene insulin-dependent diabetes mellitus 13
IDDM13 IDDM10 Gene insulin-dependent diabetes mellitus 10
IDDM14 IDDM11 Gene insulin-dependent diabetes mellitus 11
orb60745 Metformin hydrochloride Metformin hydrochloride(Glucophage) is a biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. F 10 mg
JD1H2_R2S Diabetes type 1 (juvenil diabetes) ,JD1H2:2 SignArrays
JD1H1_F8S Diabetes Type 1 (Juvenil Diabetes) ,JD1H1:8 SignArrays
JD1H1_F4S Diabetes Type 1 (Juvenil Diabetes) ,JD1H1:4 SignArrays
JD1H1_R12S Diabetes Type 1 (Juvenil Diabetes) ,JD1H1:12 SignArrays
JD1H1_R24S Diabetes Type 1 (Juvenil Diabetes) ,JD1H1:24 SignArrays

Pathways :

WP1584: Type II diabetes mellitus
WP1017: Type II interferon signaling (IFNG)
WP1289: Type II interferon signaling (IFNG)
WP1801: Diabetes pathways
WP585: Interferon type I
WP900: Type II interferon signaling (IFNG)
WP1253: Type II interferon signaling (IFNG)
WP2272: Pathogenic Escherichia coli infection
WP786: Type II interferon signaling (IFNG)
WP1136: Type II interferon signaling (IFNG)
WP1350: Type II interferon signaling (IFNG)
WP2113: Type III interferon signaling
WP619: Type II interferon signaling (IFNG)

Related Genes :
[IAPP] Islet amyloid polypeptide (Amylin) (Diabetes-associated peptide) (DAP) (Insulinoma amyloid peptide)
[PEA15] Astrocytic phosphoprotein PEA-15 (15 kDa phosphoprotein enriched in astrocytes) (Phosphoprotein enriched in diabetes) (PED)
[GCK] Hexokinase-4 (HK4) (EC 2.7.1.1) (Glucokinase) (Hexokinase type IV) (HK IV) (Hexokinase-D)
[PTPRN2 KIAA0387] Receptor-type tyrosine-protein phosphatase N2 (R-PTP-N2) (EC 3.1.3.-) (EC 3.1.3.48) (Islet cell autoantigen-related protein) (IAR) (ICAAR) (Phogrin) [Cleaved into: IA-2beta60]
[SLC2A4 GLUT4] Solute carrier family 2, facilitated glucose transporter member 4 (Glucose transporter type 4, insulin-responsive) (GLUT-4)
[Cblb] E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene b) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B)
[PTPRN ICA3 ICA512] Receptor-type tyrosine-protein phosphatase-like N (R-PTP-N) (Islet cell antigen 512) (ICA 512) (Islet cell autoantigen 3) (PTP IA-2) [Cleaved into: ICA512-N-terminal fragment (ICA512-NTF); ICA512-transmembrane fragment (ICA512-TMF); ICA512-cleaved cytosolic fragment (ICA512-CCF)]
[PTGDS PDS] Prostaglandin-H2 D-isomerase (EC 5.3.99.2) (Beta-trace protein) (Cerebrin-28) (Glutathione-independent PGD synthase) (Lipocalin-type prostaglandin-D synthase) (Prostaglandin-D2 synthase) (PGD2 synthase) (PGDS) (PGDS2)
[Ptprn2] Receptor-type tyrosine-protein phosphatase N2 (R-PTP-N2) (EC 3.1.3.-) (EC 3.1.3.48) (PTP IA-2beta) (Phogrin) (Protein tyrosine phosphatase-NP) (PTP-NP) [Cleaved into: IA-2beta71; IA-2beta64; IA-2beta60]
[Slc2a4 Glut4] Solute carrier family 2, facilitated glucose transporter member 4 (GT2) (Glucose transporter type 4, insulin-responsive) (GLUT-4)
[BSCL2] Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein)
[SLC2A2 GLUT2] Solute carrier family 2, facilitated glucose transporter member 2 (Glucose transporter type 2, liver) (GLUT-2)
[CACNA1D CACH3 CACN4 CACNL1A2 CCHL1A2] Voltage-dependent L-type calcium channel subunit alpha-1D (Calcium channel, L type, alpha-1 polypeptide, isoform 2) (Voltage-gated calcium channel subunit alpha Cav1.3)
[Ptprn] Receptor-type tyrosine-protein phosphatase-like N (R-PTP-N) (105 kDa islet cell antigen) (BEM-3) (Brain-enriched membrane-associated protein tyrosine phosphatase) (ICA105) (ICA512) (PTP IA-2) (PTPLP) [Cleaved into: ICA512-N-terminal fragment (ICA512-NTF); ICA512-transmembrane fragment (ICA512-TMF); ICA512-cleaved cytosolic fragment (ICA512-CCF)]
[SOX13] Transcription factor SOX-13 (Islet cell antigen 12) (SRY (Sex determining region Y)-box 13) (Type 1 diabetes autoantigen ICA12)
[Gck Gk] Hexokinase-4 (HK4) (EC 2.7.1.1) (Glucokinase) (Hexokinase type IV) (HK IV) (Hexokinase-D)
[Ptprn Ptp35] Receptor-type tyrosine-protein phosphatase-like N (R-PTP-N) (PTP IA-2) [Cleaved into: ICA512-N-terminal fragment (ICA512-NTF); ICA512-transmembrane fragment (ICA512-TMF); ICA512-cleaved cytosolic fragment (ICA512-CCF)]
[TRIM32 HT2A] E3 ubiquitin-protein ligase TRIM32 (EC 2.3.2.27) (72 kDa Tat-interacting protein) (RING-type E3 ubiquitin transferase TRIM32) (Tripartite motif-containing protein 32) (Zinc finger protein HT2A)
[botA atx bna bonT CLM_0897] Botulinum neurotoxin type A2 (BoNT/A) (Bontoxilysin-A) (BOTOX) [Cleaved into: Botulinum neurotoxin A2 light chain (LC) (EC 3.4.24.69); Botulinum neurotoxin A2 heavy chain (HC)]
[HNF1B TCF2] Hepatocyte nuclear factor 1-beta (HNF-1-beta) (HNF-1B) (Homeoprotein LFB3) (Transcription factor 2) (TCF-2) (Variant hepatic nuclear factor 1) (vHNF1)
[Tnf Tnfa Tnfsf2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[INPPL1 SHIP2] Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2)
[Slc2a4 Glut4] Solute carrier family 2, facilitated glucose transporter member 4 (Glucose transporter type 4, insulin-responsive) (GLUT-4)
[CLEC16A KIAA0350] Protein CLEC16A (C-type lectin domain family 16 member A)
[HNF4A HNF4 NR2A1 TCF14] Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) (Transcription factor 14) (TCF-14) (Transcription factor HNF-4)
[CCR5 CMKBR5] C-C chemokine receptor type 5 (C-C CKR-5) (CC-CKR-5) (CCR-5) (CCR5) (CHEMR13) (HIV-1 fusion coreceptor) (CD antigen CD195)
[PTPN22 PTPN8] Tyrosine-protein phosphatase non-receptor type 22 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (Lymphoid phosphatase) (LyP) (PEST-domain phosphatase) (PEP)
[PRKCB PKCB PRKCB1] Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13)
[KCNJ11] ATP-sensitive inward rectifier potassium channel 11 (IKATP) (Inward rectifier K(+) channel Kir6.2) (Potassium channel, inwardly rectifying subfamily J member 11)
[INSR] Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta]

Bibliography :
[31627238] [Multimorbidity in elder psychiatric patients].
[31626838] A sea cucumber (Holothuria leucospilota) polysaccharide improves the gut microbiome to alleviate the symptoms of type 2 diabetes mellitus in Goto-Kakizaki rats.
[31626387] Depressive Symptoms Mediate the Relationship between Sleep Disturbances and Type 2 Diabetes Mellitus.
[31625779] Increased arrhythmia susceptibility in type 2 diabetic mice related to dysregulation of ventricular sympathetic innervation.
[31625766] Development of risk models for major adverse chronic renal outcomes among patients with type 2 diabetes mellitus using insurance claims: a retrospective observational study.
[31625413] Comparison of Interstitial Fluid Glucose Levels Obtained by Continuous Glucose Monitoring and Flash Glucose Monitoring in Patients With Type 2 Diabetes Mellitus Undergoing Hemodialysis.
[31625203] Effect of microalbuminuria on corneal endothelium in patients with diabetes without retinopathy.
[31623352] The Ratio of Oxidized Lipoprotein(a) to Native Lipoprotein(a) and the Endothelial Function in Patients with Type 2 Diabetes Mellitus.
[31620571] Comparison of sevoflurane and propofol anesthesia on the incidence of hyperglycemia in patients with type 2 diabetes undergoing lung surgery.
[31622212] Evaluation of salivary antioxidants and oxidative stress markers in type 2 diabetes mellitus: A retrospective cohort study.